PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 5, 2026Cancer Research0 citations

Abstract 3778: Circulating tumor cell based ex vivo platform for characterizing circulating hybrid cell dynamics in multiple cancer types

View Full Paper
CYChia-Liang YenWJWan-Syuan JianTLTing-Chun Liu

Key Points

  • This research aims to explore the prevalence and clinical significance of circulating hybrid cells in various cancers and their potential contributions to therapy resistance.
  • Analyzed circulating tumor cell-enriched samples from patients with breast cancer, NSCLC, and colorectal cancer.
  • Identified CHCs using dual pan-cytokeratin and CD45 immunofluorescence.
  • Developed an AI-assisted image analysis platform for automated CHC quantification.
  • Conducted parallel culture with cisplatin to assess chemoresistance.
  • Distinct CHC populations displayed co-expression of epithelial and hematopoietic markers.
  • CHCs became more prominent with extended culture time, indicating progressive enrichment.
  • Initial validation showed reliable discrimination between immune and potential CHC cells.

Abstract

Abstract Circulating hybrid cells (CHCs) arising from tumor-leukocyte fusion may contribute to metastasis and therapy resistance through enhanced DNA repair, immune evasion, and acquired migratory capacity. However, the prevalence, expansion dynamics, and clinical significance of CHCs across cancer types remain poorly characterized.Circulating tumor cells (CTC)-enriched samples from patients with breast cancer, NSCLC, and colorectal cancer were analyzed through extended ex vivo culture. CHCs were identified by dual pan-cytokeratin and CD45 immunofluorescence combined with morphological criteria. An AI-assisted image analysis platform is being developed for automated CHC quantification and characterization. A subset underwent parallel culture with cisplatin to assess chemoresistance and clinical correlations with treatment history and disease status were evaluated. Initial validation demonstrates reliable discrimination between immune cells and non-immune cells (potential CTCs/CHCs), enabling systematic quantification. Dual immunofluorescence staining revealed distinct CHC populations characterized by co-expression of epithelial (pan-CK+) and hematopoietic (CD45+) markers with large cell size. CHCs were rarely observed in early culture across all cancer types but became prominent by extended culture, indicating progressive enrichment over time. Complete quantitative analysis with statistical validation is ongoing. These findings establish extended ex vivo culture as a platform for investigating CHC biology, assessing drug sensitivity, and determining clinical relevance. Citation Format: Chia-Liang Yen, Wan-Syuan Jian, Ting-Chun Liu, Pei Yu Chen, Shih-Pei Wu, Po-han Chen. Circulating tumor cell based ex vivo platform for characterizing circulating hybrid cell dynamics in multiple cancer types abstract. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 3778.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yen et al. (2026) studied this question.

synapsesocial.com/papers/69d1fdf7a79560c99a0a4549https://doi.org/10.1158/1538-7445.am2026-3778
Ask AI
Helpful
Bookmark
Share
View Full Paper